Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer

Authors:

Abstract
No abstract available
Funding Information
  • Bristol-Myers Squibb Co
  • The University of Texas MD Anderson Cancer Center

This publication has 28 references indexed in Scilit: